47 POSTER A phase II study of Sorafenib (BAY 43-9006) in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal cancer (NPC): final results.

Details

Language :

English

ISSN :

13596349

Volume :

4

Issue :

12

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

23556961

Full Text :

https://doi.org/10.1016/S1359-6349(06)70053-2